2023 Agenda Coming Soon
Agenda - Signals Summit 2022
Friday, December 2, 2022
*Times listed are in Central Standard Time
Agenda |
||
6:30 – 7:55 AM |
Breakfast with Exhibits |
|
7:55 – 8:00 AM |
Welcome / Introduction / Opening Remarks |
|
8:00 – 10:00 AM |
SESSION I: |
|
8:00 – 8:15 AM |
PRINCIPLES OF CARDIAC CONDUCTION DEDUCED FROM EXPERIMENTAL OBSERVATIONS |
|
8:15 – 8:30 AM |
MECHANISMS AND SIGNALS OF SLOW CONDUCTION IN THE HEART |
|
8:30 – 8:45 AM |
3D ACTIVATION IN REGIONS OF ELECTRICAL DISCONTINUITY |
|
8:45 – 9:00 AM |
3D ACTIVATION IN AF |
|
9:00 – 9:15 AM |
CONTRIBUTION OF HETEROGENICITY IN REPOLARIZATION FOR ARRHYTHMOGENESIS |
|
9:15 – 9:30AM |
ELECTROGENESIS OF CARDIAC BIOPOTENTIALS |
|
9:30 – 10:00 AM |
Panel Discussion with Q&A Session |
|
10:00 – 10:15 AM |
Coffee Break and Exhibits |
|
10:15 AM – 12:30 PM |
SESSION II: |
|
10:15 – 10:30 AM |
UNIPOLAR, BIPOLAR, OMNIPOLAR, AND LAPLACIAN ELECROGRAMS |
|
10:30 – 10:45 AM |
CHALLENGES IN ACCURATE MEASUREMENT OF ACTIVATION TIMES |
|
10:45 – 11:00 AM |
TRANSLATING CONDUCTION VELOCITY MEASUREMENTS FROM 2D TO 3D |
|
11:00 – 11:15 AM |
METHODOLOGICAL CONSIDERATIONS IN MAPPING FIBRILLATORY RHYTHMS |
|
11:15 – 11:30 AM |
INSIGHTS FROM HIGH-RES, HIGH-DENSITY MAPPING OF AF IN HUMANS |
|
11:30 – 11:45 AM |
MAPPING WITH PACING FORM MULTIPLE WAVEFRONT IMPROVES SUBSTRATE CHARECTERIZATION OF VT ISTHMUS SITES |
|
11:45 – 12:00 PM |
SIGNAL RECORDINGS: IDEAS TO IMPROVE CATHETER DESIGNS |
|
12:00 – 12:30 PM |
Panel Discussion with Q&A Session |
|
12:30 – 1:15 PM |
Lunch and Exhibits |
|
1:15 – 2:15 PM |
SESSION III: |
|
1:15 – 1:45 PM |
ELECTRICAL PROPAGATION IN VENTRICULAR FIBRILLATION |
|
1:45 – 2:15 PM |
Panel Discussion with Q&A Session |
|
2:15 – 4:15 PM |
SESSION IV: |
|
2:15 – 2:25 PM |
IMPLEMENTING FILTERS TO IMPROVE SIGNAL RECORDINGS |
|
2:25 – 2:35 PM |
NEAR FIELD DETECTION: RESOLVING LOCAL CONDUCTANCE IN THE SUBSTRATE |
|
2:35 – 2:45 PM |
ROLE OF SPATIOTEMPORAL ELECTROGRAM PROPAGATION IN AF MAPPING |
|
2:45 – 2:55 PM |
ELECTROGRAPHIC FLOW MAPPING IN PERSISTENT AF |
|
2:55 – 3:05 PM |
A NEW MAPPING APPROACH FOR IMPROVED SCAR DETECTION |
|
3:05 – 3:15 PM |
MAPPING AND IDENTIFYING ABLATION TARGETS DURING AF |
|
3:15 – 3:45 PM |
THE CHALLENGES OF AF MAPPING |
|
3:45 – 4:15 PM |
Panel Discussion with Q&A Session |
|
4:15 – 4:30 PM |
Break and Exhibits |
|
4:30 – 5:30 PM |
SESSION V: |
|
ABLATION APPROACH OF PERSISTENT AF WITH PFA |
||
CARDIAC NEUROMODULATION OF VASOVAGAL SYNCOPE |
||
ALCOHOL ABLATION OF PVC/VT |
||
5:30 – 6:30 PM |
Cocktail Reception with Exhibits |
|
|
|
Saturday, December 3, 2022
*Times listed are in Central Standard Time
Agenda |
||
7:00 – 8:15 AM | Breakfast and Exhibits | |
8:15 – 9:45 AM |
SESSION VI: |
|
8:15 – 8:30 AM |
COMPUTATIONAL APPROACHES FOR DIFFERENTIATING NEAR-FIELD FROM FAR-FIELD POTENTIALS |
|
8:30 – 8:45 AM |
COMPUTATIONAL MODELS OF AF TO GUIDE THERAPY |
|
8:45 – 9:00 AM |
STRATEGIES TO ADDRESS GAPS IN UNDERSTANDING ELECTRICAL SIGNALS FROM MAPPING, WEARABLE, AND IMPLANTABLE DEVICES |
|
9:00 – 9:15 AM |
DEEP LEARNING FOR RAPID CREATION OF CHAMBER GEOMETRY |
|
9:15 – 9:45 AM |
Panel Discussion with Q&A Session |
|
9:45 – 10:00 AM |
Coffee Break and Exhibits |
|
10:00 – 12:00 PM |
SESSION VII: |
|
10:00 – 10:15 AM |
ANATOMY AND ELECTROPHYSIOLOGY OF THE HIS–PURKINJE NETWORK |
|
10:15 – 10:30 AM |
AUTONOMIC GANGLIA AND THEIR ROLE IN AF |
|
10:30 – 10:45 AM |
CARDIONEUROABLATION ASSOCIATED WITH PVI |
|
10:45 – 11:00 AM |
THE VEIN OF MARSHALL AND ITS CONTRIBUTION TO AF |
|
11:00 – 11:15 AM |
BACHMANN’S BUNDLE AND ITS ROLE IN AF |
|
11:15 – 11:30 AM |
LEFT BUNDLE BRANCH PACING |
|
11:30 – 12:00 PM |
Panel Discussion with Q&A Session |
|
12:00 – 1:00 PM |
Lunch and Exhibits |
|
1:00 – 3:00 PM |
SESSION VIII: |
|
1:00 – 1:15 PM |
OPTOGENETIC SENSORS AND ACTUATORS FOR TREATING ARRHYTHMIAS |
|
1:15 – 1:30 PM |
IMMUNE RESPONSE MODULATION IN ARVC TREATMENT |
|
1:30 – 1:45 PM |
ALCOHOL ABLATION OF ARRHYTHMIAS |
|
1:45 – 2:00 PM |
INTEGRATION OF HIGH-RES MAPPING AND ABLATION IN A SINGLE CATHETER |
|
2:00 – 2:15 PM |
THE FUTURE OF CATHETER ABLATION |
|
2:15 – 2:45 PM |
Panel Discussion with Q&A Session |
|
2:45 – 3:00 PM |
Closing Thoughts and Farewell |
|
|
|
2023 Faculty Coming Soon
Faculty
Course Founder and Director |
||
Elad Anter, MD |
|
|
Course Co-Directors |
||
Pierre Jaïs, MD |
Natasja de Groot, MD, PhD |
|
Faculty |
||
Meir Bar-Tal, MSc |
Stavros Stavrakis, MD, PhD |
|
Omer Berenfeld, PhD |
Decebal Gabriel Lațcu, MD |
|
David Callans, MD |
Sanjiv Narayan, MD |
|
Edward Ciaccio, PhD |
Andrea Natale, MD |
|
Kevin Donahue, MD |
José Carlos Pachón, MD |
|
Olaf Dössel, MD |
Yoram Rudy, PhD |
|
Vadim Fedorov, PhD |
Jeffery Saffitz, MD, PhD |
|
Lior Gepstein, MD |
Kalyanam Shivkumar, MD, PhD |
|
David Haines, MD |
Bruce Smaill, PhD |
|
Michel Haïssaguerre, MD, PhD |
Peter Spector, MD |
|
Warren “Sonny” Jackman, MD |
Natalia Trayanova, PhD |
|
Jérome Kalifa, MD |
Miguel Valderrábano, MD |
|
Josef Kautzner, MD, PhD |
Pascal Van Dessel, MD |
|
Steven Kim, MSEE |
Edward Vigmond, PhD |
|
André Kléber, MD |
Gaurav Upadhyay, MD |
|
Zachary Koch, CCDS, CEPS |
Paul Wang, MD |
|
ACTIVITY DESCRIPTION
The purpose of this educational activity is to provide comprehensive education on fundamental electrophysiology concepts ranging from basic science to signal processing engineering and innovations in electrophysiology. The atmosphere will encourage open discussions and an exchange of ideas aimed at reducing barriers and providing solutions to fundamental constraints.
TARGET AUDIENCE
This course has been designed for electrophysiologists, fellows, cardiologists, biomedical engineers, scientists, and associated physicians and allied health care professionals.
Learning Objectives
At the conclusion of this educational course, participants should be able to:
- Assess Fundamentals of Electrical Propagation and Conduction Block.
- Review Challenges and Solutions of Electrogram Recordings.
- Examine Electrical Propagation During Ventricular Fibrillation.
- Evaluate Emerging Technologies and Review Advancements in Procedural Approaches.
- Assess Computational Models and Artificial Intelligence
- Examine Anatomy, Physiology, and Pacing.
- Discussion Emerging Ablation Techniques and Novel Therapies.
ACTIVITY GOAL
This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-based Learning.
ACCREDITATION
This activity has been planned and implemented by MediaSphere Medical and Ciné-Med.
Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Physicians: Ciné-Med designates this live activity for a maximum of 16 AMA PRA Category 1 Credit(s)™. Physicians should claim only the number of credits commensurate with the extent of their participation in the activity.
Nurses: Ciné-Med designates this activity for 16 Contact Hours for nurses.
Claiming CME Certificates
Signals Summit 2022 is CME-accredited for Onsite and Virtual attendees.
At the conclusion of the Signals Summit, an email will be issued that provides direct access to the post-activity CME form to claim credits for attendance. Additionally, the Claim CME Credit form will be accessible directly on the conference website.
1 CME Certificate is supplied electronically for the cumulative CME Credits earned commensurate with the extent of participation within the Signals Summit as an attendee.
DISCLOSURE POLICY
MediaSphere Medical and Ciné-Med adhere to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty’s commercial relationships will be made known at the activity on course handouts and during faculty presentations. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.
All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.
It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real or apparent conflicts of interest present within the past 12 months.
MediaSphere Medical and Ciné-Med have implemented a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. Faculty disclosures will be made available at the time of the Signals Summit.
Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verify that sound education principles have been demonstrated in the development of this educational offering as evidenced by a review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med do not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.
Day 1: Friday, December 2, 2022
*Times listed are in Central Standard Time
7:55 – 8:00 AM |
Welcome / Introduction / Opening Remarks |
|
8:00 – 10:00 AM |
SESSION I: |
|
8:00 – 8:15 AM |
PRINCIPLES OF CARDIAC CONDUCTION DEDUCED FROM EXPERIMENTAL OBSERVATIONS |
|
8:15 – 8:30 AM |
MECHANISMS AND SIGNALS OF SLOW CONDUCTION IN THE HEART |
|
8:30 – 8:45 AM |
3D ACTIVATION IN REGIONS OF ELECTRICAL DISCONTINUITY |
|
8:45 – 9:00 AM |
3D ACTIVATION IN AF |
|
9:00 – 9:15 AM |
CONTRIBUTION OF HETEROGENICITY IN REPOLARIZATION FOR ARRHYTHMOGENESIS |
|
9:15 – 9:30AM |
ELECTROGENESIS OF CARDIAC BIOPOTENTIALS |
|
9:30 – 10:00 AM |
Panel Discussion with Q&A Session |
|
10:00 – 10:15 AM |
Break |
|
10:15 AM – 12:30 PM |
SESSION II: |
|
10:15 – 10:30 AM |
UNIPOLAR, BIPOLAR, OMNIPOLAR, AND LAPLACIAN ELECROGRAMS |
|
10:30 – 10:45 AM |
CHALLENGES IN ACCURATE MEASUREMENT OF ACTIVATION TIMES |
|
10:45 – 11:00 AM |
TRANSLATING CONDUCTION VELOCITY MEASUREMENTS FROM 2D TO 3D |
|
11:00 – 11:15 AM |
METHODOLOGICAL CONSIDERATIONS IN MAPPING FIBRILLATORY RHYTHMS |
|
11:15 – 11:30 AM |
INSIGHTS FROM HIGH-RES, HIGH-DENSITY MAPPING OF AF IN HUMANS |
|
11:30 – 11:45 AM |
MAPPING WITH PACING FORM MULTIPLE WAVEFRONT IMPROVES SUBSTRATE CHARECTERIZATION OF VT ISTHMUS SITES |
|
11:45 – 12:00 PM |
SIGNAL RECORDINGS: IDEAS TO IMPROVE CATHETER DESIGNS |
|
12:00 – 12:30 PM |
Panel Discussion with Q&A Session |
|
*Special Virtual Case Theater Session During On-Site Lunch Break in Chicago |
||
12:30 – 1:10 PM |
AFib Workflow with the OCTARAY™ Mapping Catheter and TRUEref™ Technology Session Description |
|
1:10 – 1:15 PM |
Break |
|
1:15 – 2:15 PM |
SESSION III: |
|
1:15 – 1:45 PM |
ELECTRICAL PROPAGATION IN VENTRICULAR FIBRILLATION |
|
1:45 – 2:15 PM |
Panel Discussion with Q&A Session |
|
2:15 – 4:15 PM |
SESSION IV: |
|
2:15 – 2:25 PM |
IMPLEMENTING FILTERS TO IMPROVE SIGNAL RECORDINGS |
|
2:25 – 2:35 PM |
NEAR FIELD DETECTION: RESOLVING LOCAL CONDUCTANCE IN THE SUBSTRATE |
|
2:35 – 2:45 PM |
ROLE OF SPATIOTEMPORAL ELECTROGRAM PROPAGATION IN AF MAPPING |
|
2:45 – 2:55 PM |
ELECTROGRAPHIC FLOW MAPPING IN PERSISTENT AF |
|
2:55 – 3:05 PM |
A NEW MAPPING APPROACH FOR IMPROVED SCAR DETECTION |
|
3:05 – 3:15 PM |
MAPPING AND IDENTIFYING ABLATION TARGETS DURING AF |
|
3:15 – 3:45 PM |
THE CHALLENGES OF AF MAPPING |
|
3:45 – 4:15 PM |
Panel Discussion with Q&A Session |
|
4:15 – 4:30 PM |
Break |
|
4:30 – 5:30 PM |
SESSION V: |
|
ABLATION APPROACH OF PERSISTENT AF WITH PFA |
||
CARDIAC NEUROMODULATION OF VASOVAGAL SYNCOPE |
||
ALCOHOL ABLATION OF PVC/VT |
Day 2: Saturday, December 3, 2022
*Times listed are in Central Standard Time
8:15 – 9:45 AM |
SESSION VI: |
|
8:15 – 8:30 AM |
COMPUTATIONAL APPROACHES FOR DIFFERENTIATING NEAR-FIELD FROM FAR-FIELD POTENTIALS |
|
8:30 – 8:45 AM |
COMPUTATIONAL MODELS OF AF TO GUIDE THERAPY |
|
8:45 – 9:00 AM |
STRATEGIES TO ADDRESS GAPS IN UNDERSTANDING ELECTRICAL SIGNALS FROM MAPPING, WEARABLE, AND IMPLANTABLE DEVICES |
|
9:00 – 9:15 AM |
DEEP LEARNING FOR RAPID CREATION OF CHAMBER GEOMETRY |
|
9:15 – 9:45 AM |
Panel Discussion with Q&A Session |
|
9:45 – 10:00 AM |
Break |
|
10:00 – 12:00 PM |
SESSION VII: |
|
10:00 – 10:15 AM |
ANATOMY AND ELECTROPHYSIOLOGY OF THE HIS–PURKINJE NETWORK |
|
10:15 – 10:30 AM |
AUTONOMIC GANGLIA AND THEIR ROLE IN AF |
|
10:30 – 10:45 AM |
CARDIONEUROABLATION ASSOCIATED WITH PVI |
|
10:45 – 11:00 AM |
THE VEIN OF MARSHALL AND ITS CONTRIBUTION TO AF |
|
11:00 – 11:15 AM |
BACHMANN’S BUNDLE AND ITS ROLE IN AF |
|
11:15 – 11:30 AM |
LEFT BUNDLE BRANCH PACING |
|
11:30 – 12:00 PM |
Panel Discussion with Q&A Session |
|
*Special Virtual Case Theater Session During On-Site Lunch Break in Chicago |
||
12:00 – 12:45 PM |
Paroxysmal AF with FARAPULSE PFA Session Description |
|
12:45 – 1:00 PM |
Break |
|
1:00 – 3:00 PM |
SESSION VIII: |
|
1:00 – 1:15 PM |
OPTOGENETIC SENSORS AND ACTUATORS FOR TREATING ARRHYTHMIAS |
|
1:15 – 1:30 PM |
IMMUNE RESPONSE MODULATION IN ARVC TREATMENT |
|
1:30 – 1:45 PM |
ALCOHOL ABLATION OF ARRHYTHMIAS |
|
1:45 – 2:00 PM |
INTEGRATION OF HIGH-RES MAPPING AND ABLATION IN A SINGLE CATHETER |
|
2:00 – 2:15 PM |
THE FUTURE OF CATHETER ABLATION |
|
2:15 – 2:45 PM |
Panel Discussion with Q&A Session |
|
2:45 – 3:00 PM |
Closing Thoughts and Farewell |